Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) | RFA MD 18 002

Opportunity Information: Apply for RFA MD 18 002

The NIH funding opportunity "Mechanisms of Disparities for HIV-Related Co-morbidities in Health Disparity Populations (R01 - Clinical Trial Not Allowed)" (RFA-MD-18-002) is a discretionary research grant designed to support studies that explain why and how HIV-related co-morbidities create added complexity for people living with HIV/AIDS in health disparity populations. The central focus is on underlying mechanisms, meaning applicants are expected to move beyond simply documenting that disparities exist and instead investigate the biological, behavioral, social, environmental, and health-system pathways through which co-morbid conditions shape HIV disease progression, quality of life, and overall health outcomes. The initiative emphasizes that HIV does not occur in isolation for many patients, and that co-existing conditions can interact with HIV and its treatment in ways that may worsen outcomes, accelerate complications, or reduce well-being, particularly in populations that already face structural barriers to care and higher burdens of disease.

A key feature of the announcement is its explicit focus on health disparity populations and the disproportionate impact of co-morbidities within these communities. Projects supported under this R01 are intended to clarify mechanisms driving unequal outcomes, which can include interactions among co-morbidities (for example, cardiovascular disease, metabolic disorders, mental health conditions, substance use disorders, or other chronic illnesses) and HIV-related factors such as immune function, inflammation, treatment adherence, treatment toxicity, comorbidity management, and access to consistent care. By concentrating on mechanisms, the program is aimed at generating knowledge that can later inform better-targeted prevention strategies, clinical management approaches, and health system interventions, even though the funded work under this specific announcement cannot be a clinical trial.

The "Clinical Trial Not Allowed" designation means the research cannot be structured as a prospective study in which participants are assigned to an intervention to evaluate health outcomes. However, mechanistic and observational research, secondary analyses, analyses of existing cohorts, use of clinical or public health datasets, and other non-trial designs are typically consistent with this type of NIH mechanism-focused R01, as long as the work is aligned with NIH policy and the specific terms of the funding announcement. In practical terms, applicants should frame their aims around understanding causal pathways and contributors to disparities rather than testing an intervention as a trial.

This opportunity is offered as an NIH grant (Funding Instrument: Grant; Activity Category: Health) and is associated with CFDA numbers 93.121 and 93.307. The listed award ceiling is $450,000. The original application closing date was February 21, 2018, and the posting indicates it was created on November 6, 2017. While the excerpt does not provide details such as project period limits or budget format, the ceiling gives a sense of the maximum funding level referenced in the opportunity summary.

Eligibility is broad and spans many organization types, reflecting an intent to encourage participation from institutions that serve, represent, or conduct research relevant to health disparity communities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional categories of eligible applicants that often play central roles in disparity-focused research, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.

At the same time, the opportunity draws clear boundaries around foreign participation. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply as the applicant organization. Non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. In plain terms, a U.S.-based applicant may be able to include an allowable foreign component within the project if it meets NIH definitions and requirements, but foreign institutions cannot serve as the primary applicant for this particular opportunity.

Overall, this R01 is aimed at building a stronger scientific explanation for why HIV-related co-morbidities contribute to unequal HIV outcomes in disparity populations, with the expectation that clearer mechanistic understanding can eventually support better clinical management and policy or system responses. It is positioned for investigators and organizations that can connect HIV science with co-morbidity research and disparity frameworks, using rigorous, non-clinical-trial study designs to unpack the drivers of disease progression, quality of life differences, and broader health outcome gaps among affected populations.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.307.
• This funding opportunity was created on 2017-11-06.
• Applicants must submit their applications by 2018-02-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $450,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA MD 18 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: